Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02701296 · ClinicalTrials.gov registry record · NA
Posterior Capsular Injection With Femoral Nerve Block for Total Knee Arthroplasty
A NA study, sponsored by Trinity Health Of New England.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT02701296 is a NA study that has completed, run by Trinity Health Of New England. The registered enrollment target is 80 participants.
The verdict
NCT02701296, a NA study, has completed, sponsored by Trinity Health Of New England.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
To assess pain control after total knee replacement surgery using two different nerve block techniques. The 2 methods are: 1. Continuous femoral nerve block with ultrasound guided posterior capsular injection 2. Continuous femoral nerve block with ultrasound selective tibial nerve block.
Interventions
- DRUG Ropivacaine
- DRUG Ropivacaine with Epinephrine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2011-11-07 |
| Est. Completion | 2014-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02701296
The ClinicalTrials.gov registry entry for NCT02701296 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Trinity Health Of New England, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ropivacaine is the first listed.
NCT02701296 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02701296 about?
NCT02701296 is a clinical study titled "Posterior Capsular Injection With Femoral Nerve Block for Total Knee Arthroplasty". To assess pain control after total knee replacement surgery using two different nerve block techniques. The 2 methods are: 1. Continuous femoral nerve block with ultrasound guided posterior capsular injection 2. Continuous femoral nerve block with ultrasound selective tibial nerve block.
What is the current status of trial NCT02701296?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2011-11-07. Estimated completion is 2014-08-31.
What interventions are being tested in trial NCT02701296?
The interventions under investigation include: Ropivacaine (DRUG), Ropivacaine with Epinephrine (DRUG).
Who is sponsoring clinical trial NCT02701296?
This trial is sponsored by Trinity Health Of New England, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.